Jill O’Donnell-Tormey, Ph.D.
Board Member
Coherus Oncology, Inc. (CHRS)Equibles does not estimate personal net worth.
Get an email with a short summary when Coherus Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get CHRS alertsAbout Jill O’Donnell-Tormey, Ph.D.
Jill O’Donnell-Tormey, Ph.D. is recorded as Board Member at Coherus Oncology, Inc. (CHRS) since May 18, 2022. Coherus Oncology, Inc. reported in an 8-K filed May 13, 2022 that Jill O’Donnell-Tormey, Ph.D. was appointed Class II director, effective May 18, 2022. Coherus Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coherus Oncology, Inc. includes Dennis Lanfear (CEO), Bryan McMichael (CFO and Chief Accounting Officer), McDavid Stilwell (CFO) and 7 others.
“resolved that the vacancy on the Board created by such increase would be filled with the appointment of Jill O’Donnell-Tormey, Ph.D. effective May 18, 2022.”
Affiliation history
-
Current
2022-05-18–present
Company network
Leadership on record at Coherus Oncology, Inc.
- Dennis Lanfear CEO
- Bryan McMichael CFO, Chief Accounting Officer
- McDavid Stilwell CFO
- Alan C. Mendelson Board Member
- Charles Newton Board Member
- Georgia Erbez Board Member
- Jill O'Donnell-Tormey, Ph.D. Board Member
- Lee N. Newcomer Board Member
- Mark D. Stolper Board Member
- Michael Ryan Board Member